The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

In this photo is a Zepbound injection pen arranged in the ... health programs that cover it this year. Already, GLP-1 weight loss prescriptions Wegovy, Rybelsus and Saxenda—along with Ozempic ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...